LSZ, also known as Lysergic acid 2,4-dimethylazetidide, is a hallucinogenic drug and an analogue of LSD developed by the team led by David E. Nichols at Purdue University. While LSZ has subtly different effects than LSD, it appears to be slightly longer lasting and slightly more potent.
Light: 100-150 μg
Common: 150-300 μg
Strong: 300+ μg
Onset: 90-120 minutes
Total: 7-10 hours
While LSD has subtly different effects than LSD, it appears to be slightly longer lasting while also having a longer comeup.
Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption.